Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ken Toba
Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Related publications
Acute Myocardial Infarction After Administration of Low-Dose Intravenous Epinephrine for Anaphylaxis
Canadian Journal of Emergency Medicine
Emergency Medicine
Administration of Erythropoietin in Patients With Acute Myocardial Infarction: Good or Not?
Heart
Cardiovascular Medicine
Cardiology
Method for Intravenous Administration of Heparin in Myocardial Infarction
BMJ
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?
Neurology International
Neurology
Intravenous Thrombolysis in Acute Myocardial Infarction
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Hypotensive Treatment for Acute Myocardial Infarction.
BMJ
Study of Hemodialysis Patients Who Do Not Require Administration of Recombinant Human Erythropoietin.
Nihon Toseki Igakkai Zasshi
Erythropoietin-Induced Progenitor Cell Mobilisation in Patients With Acute ST-segment-elevation Myocardial Infarction and Restenosis
Thrombosis and Haemostasis
Hematology
Dose-Dependent Neurorestorative Effects of Delayed Treatment of Traumatic Brain Injury With Recombinant Human Erythropoietin in Rats
Journal of Neurosurgery
Surgery
Neurology